What is the recommended dose of adrenaline (epinephrine) for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing for Anaphylaxis

For anaphylaxis, administer epinephrine intramuscularly at a dose of 0.3-0.5 mg (0.3-0.5 mL of 1:1000 concentration) for adults and children ≥30 kg, or 0.01 mg/kg (maximum 0.3 mg) for children <30 kg, injected into the anterolateral aspect of the mid-thigh. 1, 2

Dosing Guidelines

Adults and Children ≥30 kg (66 lbs):

  • Dose: 0.3-0.5 mg
  • Concentration: 1:1000 (1 mg/mL)
  • Volume: 0.3-0.5 mL
  • Route: Intramuscular (IM) injection into anterolateral thigh
  • Frequency: Can be repeated every 5-10 minutes as necessary 1, 2

Children <30 kg (66 lbs):

  • Dose: 0.01 mg/kg (maximum 0.3 mg)
  • Concentration: 1:1000 (1 mg/mL)
  • Volume: 0.01 mL/kg (maximum 0.3 mL)
  • Route: Intramuscular (IM) injection into anterolateral thigh
  • Frequency: Can be repeated every 5-10 minutes as necessary 1, 2

Administration Route

  • The intramuscular route in the anterolateral thigh is preferred for initial treatment due to:
    • Faster absorption compared to subcutaneous injection
    • Better safety profile compared to intravenous administration
    • Ease of administration in emergency settings 1, 3

Alternative Routes in Special Circumstances

Intravenous Administration

  • When an IV line is already in place and the patient is in anaphylactic shock, IV epinephrine may be considered
  • IV dose: 0.05 to 0.1 mg (5-10% of the cardiac arrest dose)
  • Concentration: 0.1 mg/mL (1:10,000) 4

Continuous Infusion

  • For persistent anaphylactic shock or recurrence of symptoms
  • IV infusion at 5-15 μg/min
  • Allows for careful titration and avoidance of overdosing 4

Important Clinical Considerations

Timing of Administration

  • Administer immediately upon recognition of anaphylaxis
  • Delays in administration may be fatal
  • No absolute contraindications for epinephrine use in anaphylaxis 1, 3, 5

Special Populations

  • Elderly patients and those with cardiac disease, hyperthyroidism, Parkinson's disease, diabetes, or pheochromocytoma require caution but should still receive epinephrine for anaphylaxis 1

Common Pitfalls to Avoid

  1. Incorrect route selection: Avoid injecting into buttocks, digits, hands, or feet 2
  2. Delayed administration: Failure to promptly administer epinephrine is associated with increased mortality 3
  3. Incorrect dose calculation: Studies show many healthcare providers are unfamiliar with correct dosing 6, 7
  4. Inappropriate needle length: Standard auto-injector needles may be too short for obese patients or too long for small children 8
  5. Confusion with cardiac arrest dosing: The anaphylaxis dose is different from cardiac arrest dosing 6

Monitoring and Follow-up

  • Observe patients for at least 4-6 hours after symptom resolution
  • Extended observation (8-24 hours) for severe reactions or those requiring multiple epinephrine doses
  • Monitor vital signs including blood pressure, heart rate, and oxygen saturation 1

Remember that epinephrine is the cornerstone of anaphylaxis management, and prompt administration can be life-saving. The intramuscular route in the anterolateral thigh provides the optimal balance of rapid absorption and safety.

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Research

Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.